The pooled RR was 2.04 ( Fig 4A ; 95% CI 0.90, 4.62; p = 0.09), suggesting a doubled risk of poor outcome in the PIK3CA mutated group, reaching borderline significance.
← all excerpts
PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis.
1
—
—